HUTCHMED (China) (HKSE:00013) 3-Year Revenue Growth Rate

: 46.40% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

HUTCHMED (China)'s Revenue per Share for the six months ended in Dec. 2023 was HK$2.74.

During the past 12 months, HUTCHMED (China)'s average Revenue per Share Growth Rate was 84.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was 46.40% per year. During the past 5 years, the average Revenue per Share Growth Rate was 23.90% per year. During the past 10 years, the average Revenue per Share Growth Rate was 19.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of HUTCHMED (China) was 103.20% per year. The lowest was -42.00% per year. And the median was 20.75% per year.

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, HUTCHMED (China)'s 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HUTCHMED (China) 3-Year Revenue Growth Rate Distribution

For the Drug Manufacturers industry and Healthcare sector, HUTCHMED (China)'s 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where HUTCHMED (China)'s 3-Year Revenue Growth Rate falls into.

HUTCHMED (China) 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

HUTCHMED (China) (HKSE:00013) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

HUTCHMED (China) 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of HUTCHMED (China)'s 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

HUTCHMED (China) (HKSE:00013) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HUTCHMED (China) Ltd (HKSE:00013) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

HCM:USA HCM.GB:UK HCM:UK H7T2:Germany

Address

2 Queen's Road Central, 48th Floor, Cheung Kong Center, Hong Kong, HKG

Website

https://www.hutch-med.com

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

HUTCHMED (China) (HKSE:00013) Headlines

No Headlines